AIDS-Related Cancer and Severity of Immunosuppression in Persons With AIDS
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The incidence of Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer has been declining among persons with AIDS. We investigated the association between cancer risk and CD4 cell count among such persons. METHODS: Data from US AIDS registries were linked to local cancer registry data. Cancer incidence per 100,000 person-years was determined for the 4-27 months from the onset of AIDS from January 1, 1990, through December 31, 1995--before highly active antiretroviral therapy (HAART) became available--and from January 1, 1996, through December 31, 2002. The relationships between CD4 count at AIDS onset and cancer incidence were assessed by proportional hazards models. RESULTS: Among 325,516 adults with AIDS, the incidence of Kaposi sarcoma was lower in 1996-2002 (334.6 cases per 100,000 person-years) than in 1990-1995 (1838.9 cases per 100,000 person-years), and the incidence of non-Hodgkin lymphoma followed a similar pattern (i.e., 390.1 cases per 100,000 person-years in 1996-2002 and 1066.2 cases per 100,000 person-years in 1990-1995). In 1996-2002, for each decline in CD4 cell count of 50 cells per microliter of blood, increased risks were found for Kaposi sarcoma (hazard ratio [HR] = 1.40, 95% confidence interval [CI] = 1.33 to 1.50), for central nervous system non-Hodgkin lymphoma subtypes (HR = 1.85, 95% CI = 1.58 to 2.16), and for non-central nervous system diffuse large B-cell lymphoma (HR = 1.12, 95% CI = 1.04 to 1.20) but not for non-central nervous system Burkitt lymphoma (HR = 0.93, 95% CI = 0.81 to 1.06). Cervical cancer incidence was higher in 1996-2002 (86.5 per 100,000 person-years) than in 1990-1995 (64.2 per 100,000 person-years), although not statistically significantly so (relative risk [RR] = 1.41, 95% CI = 0.81 to 2.46). After adjustment for age, race, and sex or mode of HIV exposure, the risks for Kaposi sarcoma (RR = 0.22, 95% CI = 0.20 to 0.24) and for non-Hodgkin lymphoma (RR = 0.40, 95% CI = 0.36 to 0.44) were lower in the period of 1996-2002 than in 1990-1995. Similar relationships of these cancers to CD4 count were observed for 1990-1995. CONCLUSIONS: Both before and after HAART was available, CD4 count was strongly associated with risks for Kaposi sarcoma and non-Hodgkin lymphoma but not for cervical cancer and Burkitt lymphoma. The decreasing incidences of most AIDS-associated cancers in persons with AIDS during the 1990s are consistent with improving CD4 counts after HAART introduction in 1996.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V, Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,270
Surveillance for dracunculiasis, 1981-1991.
Hopkins, D. R., & Ruiz‐Tiben, E. (1992) · PubMed · Cited by 1,110
Frisch, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1500 · Cited by 885
Nonparametric Statistical Methods, 2nd, Ed.
Borror, C. M. (2001) · Journal of Quality Technology · doi:10.1080/00224065.2001.11980073 · Cited by 874
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
Trends in cancer risk among people with AIDS in the United States 1980–2002
Engels, E. A., Pfeiffer, R. M., Goedert, J. J., Virgo, P., McNeel, T. S., Scoppa, S. M., & Biggar, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000238411.75324.59 · Cited by 775
Self-citationSpectrum of AIDS-associated malignant disorders
Goedert, J. J., Coté, T. R., Virgo, P., Scoppa, S. M., Kingma, D. W., Gail, M. H., Jaffe, E. S., & Biggar, R. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09028-4 · Cited by 701
Self-citationInternational Collaboration on HIV and Cancer (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1823 · Cited by 647
Sterne, J. A., Hernán, M. A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P., Rickenbach, M., Robins, J. M., & Egger, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67022-5 · Cited by 557
Strickler, H. D., Burk, R. D., Fazzari, M., Anastos, K., Minkoff, H., Massad, L. S., Hall, C., Bacon, M., Levine, A. M., Watts, D. H., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji073 · Cited by 519
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
Self-citationKaufmann, G. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2187 · Cited by 409
AMC-werkgroeplid, O. M., & Coutinho, R. A. (2000) · JNCI Journal of the National Cancer Institute · Cited by 382
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Besson, C., Goubar, A., Gabarre, J., Rozenbaum, W., Pialoux, G., Châtelet, F.-P., Katlama, C., Charlotte, F., Dupont, B., Brousse, N., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2339 · Cited by 378
Herida, M., Mary-Krause, M., Kaphan, R., Cadranel, J., Poizot-Martin, I., Rabaud, C., Plaisance, N., Tissot-Dupont, H., Boue, F., Lang, J.-M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.096 · Cited by 339
Immune Deficiency and Risk for Malignancy Among Persons with AIDS
Mbulaiteye, S. M., Biggar, R. J., Goedert, J. J., & Engels, E. A. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200304150-00010 · Cited by 233
Self-citationHarris, T. G. (2005) · JAMA · doi:10.1001/jama.293.12.1471 · Cited by 199
Detels, R., Tarwater, P., Phair, J. P., Margolick, J., Riddler, S. A., & Muñoz, A. (2001) · AIDS · doi:10.1097/00002030-200102160-00008 · Cited by 187
Krischer, J., Rutschmann, O., Hirschel, B. J., Vollenweider-Roten, S., Saurat, J. ‐., & Péchère, M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70124-0 · Cited by 54
Kaufmann, G. R., Perrin, L. H., Pantaleo, G., Opravil, M., Furrer, H., Telenti, A., Hirschel, B. J., Ledergerber, B., Vernazza, P., Bernasconi, E., et al. (2017) · Cited by 18
Cited by
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Cancer Burden in the HIV-Infected Population in the United States
Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., Bhatia, K., Uldrick, T. S., Yarchoan, R., Goedert, J. J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr076 · Cited by 778
Self-citationRisk of Human Papillomavirus–Associated Cancers Among Persons With AIDS
Chaturvedi, A. K., Madeleine, M. M., Biggar, R. J., & Engels, E. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp205 · Cited by 523
Self-citationA Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals
Shiels, M. S., Cole, S. R., Kirk, G. D., & Poole, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b327ca · Cited by 516
Hernández-Ramírez, R. U., Shiels, M. S., Dubrow, R., & Engels, E. A. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30125-x · Cited by 507
Self-citation
Metadata
- Authors
- Biggar, R. J., Chaturvedi, A. K., Goedert, J. J., Engels, E. A., & Study, F. T. H. C. M.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-12
- Volume
- 99
- Issue
- 12
- Pages
- 962-972
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2156984457
- Cited by
- 353
- References
- 29
- FWCI
- 13.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.